212 related articles for article (PubMed ID: 31570773)
1. Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis.
Krstic M; Hassan HM; Kolendowski B; Hague MN; Anborgh PH; Postenka CO; Torchia J; Chambers AF; Tuck AB
Lab Invest; 2020 Mar; 100(3):400-413. PubMed ID: 31570773
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
3. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
[TBL] [Abstract][Full Text] [Related]
4. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines.
Fan W; Huang X; Chen C; Gray J; Huang T
Cancer Res; 2004 Aug; 64(15):5132-9. PubMed ID: 15289316
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.
Cook AC; Chambers AF; Turley EA; Tuck AB
J Biol Chem; 2006 Aug; 281(34):24381-9. PubMed ID: 16807238
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
8. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract][Full Text] [Related]
9. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
10. TBX3 and its splice variant TBX3 + exon 2a are functionally similar.
Hoogaars WM; Barnett P; Rodriguez M; Clout DE; Moorman AF; Goding CR; Christoffels VM
Pigment Cell Melanoma Res; 2008 Jun; 21(3):379-87. PubMed ID: 18444963
[TBL] [Abstract][Full Text] [Related]
11. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness.
Perkhofer L; Walter K; Costa IG; Carrasco MC; Eiseler T; Hafner S; Genze F; Zenke M; Bergmann W; Illing A; Hohwieler M; Köhntop R; Lin Q; Holzmann KH; Seufferlein T; Wagner M; Liebau S; Hermann PC; Kleger A; Müller M
Stem Cell Res; 2016 Sep; 17(2):367-378. PubMed ID: 27632063
[TBL] [Abstract][Full Text] [Related]
12. [Tbx3 upregulation may be one of the malignant biomarkers of breast cancer].
Chen ZH; Lv GM; Ji TH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):765-7. PubMed ID: 19403417
[TBL] [Abstract][Full Text] [Related]
13. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
[TBL] [Abstract][Full Text] [Related]
14. T-box 3 negatively regulates osteoblast differentiation by inhibiting expression of osterix and runx2.
Govoni KE; Linares GR; Chen ST; Pourteymoor S; Mohan S
J Cell Biochem; 2009 Feb; 106(3):482-90. PubMed ID: 19115250
[TBL] [Abstract][Full Text] [Related]
15. MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis.
Levenson AS; Thurn KE; Simons LA; Veliceasa D; Jarrett J; Osipo C; Jordan VC; Volpert OV; Satcher RL; Gartenhaus RB
Cancer Res; 2005 Dec; 65(23):10651-6. PubMed ID: 16322206
[TBL] [Abstract][Full Text] [Related]
16. Inorganic phosphate induces cancer cell mediated angiogenesis dependent on forkhead box protein C2 (FOXC2) regulated osteopontin expression.
Lin Y; McKinnon KE; Ha SW; Beck GR
Mol Carcinog; 2015 Sep; 54(9):926-34. PubMed ID: 24700685
[TBL] [Abstract][Full Text] [Related]
17. An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines.
Paul A; Limon MBH; Hossain MM; Raza MT
J Biomol Struct Dyn; 2023 Apr; 41(7):3025-3041. PubMed ID: 35253621
[TBL] [Abstract][Full Text] [Related]
18. The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer.
Douglas NC; Papaioannou VE
J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):143-7. PubMed ID: 23624936
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
20. Reduced activity and cytoplasmic localization of Runx2 is observed in C3h10t1/2 cells overexpressing Tbx3.
Deepak V; Zhang Z; Meng L; Zeng X; Liu W
Cell Biochem Funct; 2011 Jun; 29(4):348-50. PubMed ID: 21455926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]